Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip J Saylor

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Asian Journal of Andrology|January 18, 2014
Bone targeted therapies for the prevention of skeletal morbidity in men with prostate cancerPhilip J Saylor
Journal of the National Comprehensive Cancer Network : JNCCN|June 27, 2009
New treatments for renal cell carcinoma: targeted therapiesPhilip J Saylor, M Dror Michaelson
The Journal of Urology|March 17, 2009
Metabolic complications of androgen deprivation therapy for prostate cancerPhilip J Saylor, Matthew R Smith
Journal of the National Comprehensive Cancer Network : JNCCN|February 10, 2010
Adverse effects of androgen deprivation therapy: defining the problem and promoting health among men with prostate cancerPhilip J Saylor, Matthew R Smith
The Journal of Urology|December 14, 2012
Metabolic complications of androgen deprivation therapy for prostate cancerPhilip J Saylor, Matthew R Smith
The Oncologist|January 24, 2012
Should the denosumab metastasis prevention trial change practice for men with nonmetastatic prostate cancer?Philip J Saylor, M Dror Michaelson
Clinical Genitourinary Cancer|March 3, 2012
Importance of fibroblast growth factor receptor in neovascularization and tumor escape from antiangiogenic therapyPhilip J Saylor, Bernard Escudier, M Dror Michaelson
Clinical Genitourinary Cancer|January 7, 2011
Contemporary therapeutic approaches targeting bone complications in prostate cancerRichard J Lee, Philip J Saylor, Matthew R Smith
Bone|July 13, 2010
Treatment and prevention of bone complications from prostate cancerRichard J Lee, Philip J Saylor, Matthew R Smith
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2012
Prospective study of changes in the metabolomic profiles of men during their first three months of androgen deprivation therapy for prostate cancerPhilip J Saylor, Edward D Karoly, Matthew R Smith
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Asian Journal of Andrology|January 18, 2014
Bone targeted therapies for the prevention of skeletal morbidity in men with prostate cancerPhilip J Saylor
Journal of the National Comprehensive Cancer Network : JNCCN|June 27, 2009
New treatments for renal cell carcinoma: targeted therapiesPhilip J Saylor, M Dror Michaelson
The Journal of Urology|March 17, 2009
Metabolic complications of androgen deprivation therapy for prostate cancerPhilip J Saylor, Matthew R Smith
Journal of the National Comprehensive Cancer Network : JNCCN|February 10, 2010
Adverse effects of androgen deprivation therapy: defining the problem and promoting health among men with prostate cancerPhilip J Saylor, Matthew R Smith
The Journal of Urology|December 14, 2012
Metabolic complications of androgen deprivation therapy for prostate cancerPhilip J Saylor, Matthew R Smith
The Oncologist|January 24, 2012
Should the denosumab metastasis prevention trial change practice for men with nonmetastatic prostate cancer?Philip J Saylor, M Dror Michaelson
Clinical Genitourinary Cancer|March 3, 2012
Importance of fibroblast growth factor receptor in neovascularization and tumor escape from antiangiogenic therapyPhilip J Saylor, Bernard Escudier, M Dror Michaelson
Clinical Genitourinary Cancer|January 7, 2011
Contemporary therapeutic approaches targeting bone complications in prostate cancerRichard J Lee, Philip J Saylor, Matthew R Smith
Bone|July 13, 2010
Treatment and prevention of bone complications from prostate cancerRichard J Lee, Philip J Saylor, Matthew R Smith
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2012
Prospective study of changes in the metabolomic profiles of men during their first three months of androgen deprivation therapy for prostate cancerPhilip J Saylor, Edward D Karoly, Matthew R Smith
Pageof 5